FAM116A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.870400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.695900E-02
Normal-vs-Stage2
2.819700E-02
Normal-vs-Stage3
5.402000E-03
Normal-vs-Stage4
1.758410E-01
Stage1-vs-Stage2
8.148200E-01
Stage1-vs-Stage3
4.068400E-02
Stage1-vs-Stage4
3.770200E-01
Stage2-vs-Stage3
2.980500E-02
Stage2-vs-Stage4
2.819000E-01
Stage3-vs-Stage4
1.821040E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.867900E-02
Normal-vs-AfricanAmerican
1.296450E-01
Normal-vs-Asian
4.356100E-02
Caucasian-vs-AfricanAmerican
8.067800E-01
Caucasian-vs-Asian
5.939600E-01
AfricanAmerican-vs-Asian
9.098200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.332100E-02
Normal-vs-Female
2.731700E-02
Male-vs-Female
5.904000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.797900E-02
Normal-vs-Age(41-60Yrs)
7.908400E-02
Normal-vs-Age(61-80Yrs)
2.147700E-02
Normal-vs-Age(81-100Yrs)
1.051970E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.312200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.707800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.642200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.942800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.149700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.272000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.384000E-02
Normal-vs-Daily Drinker
2.655600E-02
Normal-vs-Weekly Drinker
2.541700E-02
Normal-vs-Occasional Drinker
7.449900E-02
Normal-vs-Social Drinker
1.023990E-01
Non Drinker-vs-Daily Drinker
8.080800E-01
Non Drinker-vs-Weekly Drinker
7.946600E-01
Non Drinker-vs-Occasional Drinker
3.080600E-01
Non Drinker-vs-Social Drinker
4.185600E-01
Daily Drinker-vs-Weekly Drinker
9.676600E-01
Daily Drinker-vs-Occasional Drinker
2.490800E-01
Daily Drinker-vs-Social Drinker
3.483200E-01
Weekly Drinker-vs-Occasional Drinker
2.683600E-01
Weekly Drinker-vs-Social Drinker
3.680000E-01
Occasional Drinker-vs-Social Drinker
9.162600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.263200E-01
Normal-vs-Grade 2
2.540000E-02
Normal-vs-Grade 3
3.020200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.788000E-02
Grade 1-vs-Grade 3
5.494200E-02
Grade 1-vs-Grade 4
2.263200E-01
Grade 2-vs-Grade 3
9.824000E-01
Grade 2-vs-Grade 4
2.540000E-02
Grade 3-vs-Grade 4
3.020200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.780200E-03
Normal-vs-NonDiabetic
3.033600E-02
Diabetic-vs-NonDiabetic
7.772100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.045190E-01
Normal-vs-NoPancreatitis
1.892480E-02
Pancreatitis-vs-NoPancreatitis
7.399200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.110000E-02
Normal-vs-N1
2.723700E-02
N0-vs-N1
7.579000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.216100E-02
Normal-vs-TP53-NonMutant
1.178230E-01
TP53-Mutant-vs-TP53-NonMutant
4.934200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
